{"tid":1878117,"cid":18,"subCid":0,"title":"è‚ºç‚æœ€å¾Œä¸€ç¯‡","createTime":"2020-02-13T11:53:46.000Z","updateTime":"2020-02-13T20:38:01.000Z","uid":194326,"like":4,"dislike":1,"uniUserReply":2,"replies":[{"pid":"78c2277de0d022daf36d5dd8dc472a6e77bc8095","tid":1878117,"uid":194326,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-02-13T11:53:46.000Z","msg":"å‰è¨€<br />\n<br />\né‡è¦†å˜…é‡å””æœƒå†è¬›ï¼Œç¶²ä¸Šå¤§æŠŠKOLè¬›å˜…é‡å²©åˆå¥½éŒ¯åˆå¥½ï¼Œå¤§éƒ¨ä»½éƒ½ä¿‚irrefutableã€‚æ—¢ç„¶æˆ‘ä¸€è€Œå†ï¼Œå†è€Œä¸‰é‡ç”³éå†‡äº‹å””å¥½å‡ºè¡—ã€‚<br />\n<br />\nå¥½å¤šäººéƒ½è©±å«ç­å°ˆå®¶é£Ÿå±ï¼Œå…©æ˜ŸæœŸåˆå…©æ˜ŸæœŸï¼Œç©¶ç«Ÿå¹¾æ™‚å…ˆæœ‰ç¤¾å€å¤§çˆ†ç™¼ã€‚ä¿‚timelineé»è¬›ï¼Œå°ˆå®¶ç•¶ç„¶æœƒé æ–™æ–°å¹´æœƒå¤šå’—äººèˆ‡äººä¹‹é–“å˜…æ¥è§¸ã€‚ä¹‹ä½†ä¿‚éš»ç—…æ¯’æœªé»åˆ°é¦™æ¸¯ï¼Œé»transmitï¼Ÿ<br />\n<br />\næƒ…äººç¯€ä¿‚ä¸€å€‹é—œå¡ã€‚å°¤å…¶ä½ è¦‹èº«é‚Šç­æœ‹å‹ç•¶ç—…æ¯’ä¿‚æµæ–™ï¼Œä»²å¯ä»¥ç¹¼çºŒsocial lifeï¼Œæˆ‘ä¿‚ä½ å°±åŒä½¢çµ•äº¤ï¼Œæ©«æ‚ä½¢éƒ½å””æœƒé•·å‘½å¾—å»é‚Šã€‚æ‰€ä»¥æ¥ä¸‹ä¾†å‘¢å…©å€‹æ˜ŸæœŸä»²ç·Šè¦éæ–°å¹´ã€‚<br />\n<br />\næ­£é¡Œ<br />\n<br />\næˆ‘ä¸‰æ˜ŸæœŸå‰å·²ç¶“è¬›é<br />\n<br />\n//å’incubate ç·Šå˜…tourists é»ç¯©èµ° ?//<br />\n<a href=\"https://lihkg.com/thread/1831396/page/1\" data-auto-link target=\"_blank\">https://lihkg.com/thread/1831396/page/1</a><br />\n<br />\nçµæœçœŸä¿‚æœ‰ç­incubateç·Šå˜…ç—…äººé»å·¦é¦™æ¸¯ã€‚<br />\næ­£å¦‚æˆ‘æ‰€è¬›ï¼Œç•¶ä½ å””çŸ¥å€‹mechanism of transmissionï¼Œæ”¿åºœå””è‚¯å°é—œï¼Œå’å”¯æœ‰è‡ªå·±å°é—œï¼ˆæˆ‘æŒ‡ç·Šä½ åº¦é–€ï¼‰ã€‚Survival è©±å°±å¯ä»¥ç”¨antiseptics è§£æ±ºï¼Œå’incubationå‘¢ï¼ŸåŠ åŸ‹asymptomatic ï¼Œå…¶å¯¦ä»¶äº‹ä¿‚å¤§é‘Šåº¦æ¶resources äº¦éƒ½å””ç®—ä¿‚ä»¶éä»½å˜…äº‹ã€‚ä½ è©±ä½¢åœ°over-reactï¼Œä¸å¦‚æˆ‘å•è¿”ä½ ä¸­æ‹›å€‹riskä¸«ï¼Ÿ<br />\n<br />\nå¥½å¤šäººå°‡ç§‘å­¸ç•¶æˆå®—æ•™å’å´‡æ‹œã€‚æœ€å¾Œå¥½å¤šäººéƒ½å› ç‚ºç‡å””åˆ°è€Œè¿”è¿”å»status quo, i.e. åƒå–ç©æ¨‚æŒ½ã€‚<br />\nä¿‚å•Šï¼Œåª¾å¥³å¥½éç™®å•Šï¼Œäº¦éƒ½ä¿‚åšç”Ÿæ„å¥½æ™‚å€™ã€‚ä½†ä¿‚å’å˜…ç’°å¢ƒåº•ä¸‹ï¼Œä»²å‡ºä¹œè¡—ï¼ŸNonetheless,è½æ—¥ä¾ç„¶æœƒæœ‰ä¸€å¤§äººå‡ºè¡—éç¯€ã€‚<br />\n<br />\nç„¶å¾Œå›åˆ°å»æˆ‘ï¼‘æœˆï¼•æ—¥è¬›éå˜…é‡<br />\n//&hellip; when shit gets serious, a mask is just a placebo&hellip;//<br />\n<br />\nFinal thoughts<br />\n<br />\nQ1. äº‹å¾Œä¸¸è¦é»é£Ÿ?<br />\nA1. è‡ªå·±æµé†«ç”Ÿï¼Œè—¥æˆ¿ä½¬å•ã€‚ä¹‹å‰æˆ‘è¦‹éé¦™æ¸¯æœ‰ç­studentsæå’—å€‹pageæ•™äººé£Ÿè—¥ï¼Œå…¶ä¸­æœ‰æåˆ°plan Bã€‚ä½†ä¿‚å¦‚æœä½ ç†Ÿå‘¢éš»è—¥ä¿‚ä¹œé‡äººé£Ÿï¼Œæ ¹æœ¬å†‡äººæœƒä¿‚ç¶²ä¸Šæ•™ã€‚<br />\n<br />\nQ2. ç›²æ¶ç­å‹ä¿‚å’ªæˆ‡é³©<br />\nA2. æˆ‘å””ç›´æ¥å»ç­”ä½ ï¼Œç”¨ä¾‹å­ç­”ã€‚æ—©å¹¾å€‹æ˜ŸæœŸå…¬å¸å¤§æ¸›åƒ¹ï¼Œå¥½å¤šå»ç´™è³£å¾—å¹³éè¶…ç´šå¸‚å ´ï¼Œæ‰€ä»¥è€ç´°åŒæˆ‘è¦‹è²¨åˆ°æœé™£æœªä¸Šæ¶å°±æ”¶å®šå¹¾æ¢ä¿‚staffroomï¼Œæ”¶å·¥å…ˆè²·ã€‚å³ä¿‚å’ï¼Œä½ ç¬‘äººæˆ‡é³©å›¤å¹¾ç™¾æ¢å»ç´™æœé™£ï¼Œæœ‰å†‡è«—éå‘¢å•²å˜¢ä»Šæ—¥å””ç”¨ï¼Œè½æ—¥éƒ½æœƒç”¨ï¼Ÿæ›è¨€ä¹‹æœ‰å¾—stockå°±stockã€‚å…¬ä»”éºµå»ç´™ç‰™è†bilibalaæ—¥ç”¨å“è²·å®šå›¤ä¿‚åº¦ï¼Œèµ·ç¢¼çœŸä¿‚å¤§çˆ†ç™¼æœé™£å°±å””é§›ç‰¹ç™»ç”¨æ¢å‘½å†’éšªå»è²·ã€‚å°±ç®—æœ€å¾Œå†‡äº‹ï¼Œå‘¢æ¨£consumable éƒ½æœƒæœ‰ç”¨å®Œå˜…ä¸€æ—¥å•¦ã€‚<br />\n<br />\nQ3. ç½·å·¥é»ç‡ï¼Ÿ<br />\nA3. ç®—æŠŠå•¦ï¼Œæœ‰å¹¾å¤šå«äººç½·å·¥ä»²ä¿‚é¦™æ¸¯è¿”ç·Šå·¥ï¼Ÿè€Œè¿”ç·Šå·¥åˆæœ‰å¹¾å¤šäººæœƒéŸ¿æ‡‰ç½·å·¥ï¼Ÿé‹å‹•æœ‰å†‡Connectåˆ°é¦™æ¸¯äººï¼Ÿæœ‰ã€‚ä¸éåŒç—…æ¯’å°æ¯”ï¼Œç—…æ¯’connectåˆ°å€‹spectrumä»²å»£éå¹¾å»¿æ¢äººå‘½æ›è¿”é»å˜…é‹å‹•ã€‚<br />\n<br />\nQ4. é»ç‡æ´¾å£ç½©ï¼ŒåŒæ¶å£ç½©ã€‚<br />\nA4. ä¸Šç¶²æŠ½å£ç½©ä»¤æˆ‘è«—èµ·ç”¨botæ’éšŠæŠ½iphoneã€‚æœ‰programå˜…äººè‡ªç„¶æœ‰æ›´å¤šresourcesï¼Œè€Œç•¶ä½ æœ‰æ›´å¤šresources æœé™£ä½ æœƒconsider the society as a whole or yourself alone? å‘¢å¹¾æ—¥è¦‹åˆ°surgical maskéƒ½å¯ä»¥ç‚’åˆ°å¹¾ç™¾èšŠä¸€ç›’ï¼Œå¥½è€å¯¦ï¼Œtouch woodè¬›å¥ï¼Œä¸­æ‹›å³åˆ»å¹«è¥¯å‘¢ç­æ’šæ¨£ã€‚<br />\né›–ç„¶è©±å°±å°å½¢è±¡å¥½ï¼Œä½†ä¿‚å£ç½©å°±å’ªæ´¾å•¦ã€‚æ’éšŠé»¨ä¿‚ä¸€å€‹å•é¡Œï¼Œæ´¾å””æ´¾åˆ°ä¿¾æœ‰éœ€è¦å‡ºè¡—å˜…äººåˆä¿‚ä¸€å€‹å•é¡Œï¼Œå¦å¤–å¥½å””æ˜ç™½ä¸€æ¨£é‡ï¼Œé»è§£å””é§›å‡ºè¡—å˜…äººåè€Œä¿‚priorityï¼Ÿ<br />\n<br />\næœ€å¾Œå˜…æœ€å¾Œ<br />\n1. ç”Ÿæ´»ç”¨å“ï¼Œé£Ÿç‰©ï¼Œç”šè‡³æ°´éƒ½å„²å®š<br />\n2. é•·æœŸç—…æ‚£ï¼Œè€Œä¸”å—è—¥ç‰©æ§åˆ¶å˜…ï¼Œå°±é…å®šå¹¾å€‹æœˆå˜…è—¥å…ˆå•¦<br />\nCrestor/Lipitor/Twynsta/Norvasc/Xalatan/Xalacom/Humira/Spiriva/Imdur/Diabex/Insulins/Maxidex/Zoloft/Prozac/Cymbalta/Prednisone/Janumet/Coversyl/Nexium/OCPs/Glucagon/Keppra/Sigmacort/Advantan &hellip; etc<br />\n3. æ€¥æ•‘ç”¨å“éƒ½è¦è²·å®šæ¶å•¦ï¼Œå»å¾—è—¥æˆ¿éƒ½ä¿‚ç—…äººå¤šã€‚é£Ÿå””åˆ°äºŒæ‰‹ç—…æ¯’ï¼Œä¸‰æ‰‹éƒ½ä¸€æ¨£æœ‰ä½¢å€‹potential threat<br />\nNitrolingual/Ventolin/Epipen/Claratyne/BandAids/Antiseptics &hellip;. Etc<br />\n<br />\nè€Œå®¶æˆ‘å€‹äººå°±ä¿‚å¤–åœ‹ï¼Œä½ è¦æˆ‘å¹«ä½ è²·å˜¢ä¿‚å†‡å•é¡Œã€‚ä¹‹ä½†ä¿‚æˆ‘è¦è¿”å·¥ï¼Œæœ‰æ™‚é–“å…ˆå¯„åˆ°ä½ æƒ³è²·å˜…é‡ã€‚<br />\nå’å•¦ï¼Œä½ æœ‰éœ€è¦å°±ä¿¾æ¢listæˆ‘ï¼Œæˆ‘ç‡ä¸‹ç Œå””ç Œåˆ°ã€‚åƒ¹éŒ¢å°±è·Ÿè¿”å…¬å¸åƒ¹ï¼Œç”¨åŸ‹staff discountåˆé»è©±ï¼Ÿä¸éï¼Œshipment è‡ªè²»ã€‚<br />\n<br />\n<a href=\"https://www.facebook.com/Nusinersen194326\" data-sr-url=\"https://r.lihkg.com/link?u=https%3A%2F%2Fwww.facebook.com%2FNusinersen194326&d=3BA04jbrysekxL3Ytp5IvUtjIx4W8g%2FGk507jgkcous%3D&h=cb91c3ce\" data-auto-link target=\"_blank\">https://www.facebook.com/Nusinersen194326</a>"},{"pid":"22c79cc7c0e3d1b72be65627d15cd1a106c81145","tid":1878117,"uid":253119,"like":1,"dislike":0,"score":1,"citedBy":1,"replyTime":"2020-02-13T15:32:28.000Z","msg":"æ¨“ä¸»ä½ å¥½<br />\n<br />\næƒ³å•å“å¦‚æœç‡ä»¥ä¸‹åœ–<br />\nå› ç‚ºç—…æ¯’ğŸ¦ ä¿‚æœ‰7å€‹mutation <br />\næ‰€ä»¥å…ˆæœ‰ä¸åŒç¨‹åº¦å˜…æ„ŸæŸ“åŠ›åŒè‡´å‘½ç‡<br />\n<br />\næŠ‘æˆ–å…¶å¯¦æµé€šå˜…ç—…æ¯’<br />\nç”šè‡³ä¹å¤šæ–¼ä¸€é¡ï¼Ÿ<br />\nè¬è¬<br />\n<br />\n<img src=\"https://na.cx/i/Ct1bwr2.png\" data-thumbnail-src=\"https://i.lih.kg/thumbnail?u=https%3A%2F%2Fna.cx%2Fi%2FCt1bwr2.png&h=e5aa0cde&s={SIZE}\" />"},{"pid":"17969f2fc4a626717830604d6a4fb58d7a4c7827","tid":1878117,"uid":194326,"like":0,"dislike":0,"score":0,"quote":{"pid":"22c79cc7c0e3d1b72be65627d15cd1a106c81145","tid":1878117,"uid":253119,"like":1,"dislike":0,"score":1,"citedBy":1,"replyTime":"2020-02-13T15:32:28.000Z","msg":"æ¨“ä¸»ä½ å¥½<br />\n<br />\næƒ³å•å“å¦‚æœç‡ä»¥ä¸‹åœ–<br />\nå› ç‚ºç—…æ¯’ğŸ¦ ä¿‚æœ‰7å€‹mutation <br />\næ‰€ä»¥å…ˆæœ‰ä¸åŒç¨‹åº¦å˜…æ„ŸæŸ“åŠ›åŒè‡´å‘½ç‡<br />\n<br />\næŠ‘æˆ–å…¶å¯¦æµé€šå˜…ç—…æ¯’<br />\nç”šè‡³ä¹å¤šæ–¼ä¸€é¡ï¼Ÿ<br />\nè¬è¬<br />\n<br />\n<img src=\"https://na.cx/i/Ct1bwr2.png\" data-thumbnail-src=\"https://i.lih.kg/thumbnail?u=https%3A%2F%2Fna.cx%2Fi%2FCt1bwr2.png&h=e5aa0cde&s={SIZE}\" />"},"citedBy":0,"replyTime":"2020-02-13T20:38:01.000Z","msg":"<img src=\"https://na.cx/i/bQPwx60.png\" data-thumbnail-src=\"https://i.lih.kg/thumbnail?u=https%3A%2F%2Fna.cx%2Fi%2FbQPwx60.png&h=47962b83&s={SIZE}\" /> <br />\n<br />\n<blockquote> This is a picture of a phylogenetic tree. In a phylogenetic tree, related viruses are grouped together on branches. Influenza viruses whose HA genes&rsquo; share the same genetic changes and who also share a common ancestor (node) are grouped into specific &ldquo;clades&rdquo; and &ldquo;sub clades.&rdquo; These clades and sub-clades are alternatively sometimes called &ldquo;groups&rdquo; and &ldquo;sub-groups.&rdquo;</blockquote><br />\n<a href=\"https://www.cdc.gov/flu/about/viruses/types.htm\" data-sr-url=\"https://r.lihkg.com/link?u=https%3A%2F%2Fwww.cdc.gov%2Fflu%2Fabout%2Fviruses%2Ftypes.htm&d=3BA04jbrysekxL3Ytp5IvUtjIx4W8g%2FGk507jgkcous%3D&h=2c12934d\" data-auto-link target=\"_blank\">https://www.cdc.gov/flu/about/viruses/types.htm</a><br />\n<br />\nå””åŒmutations æœ‰å””åŒä½œç”¨ e.g. hemagglutinin &amp; neuraminidase <br />\n<br />\nè€Œç”¨MERSé»åšä¾‹å­é»è§£CoVå’æŠŠç‚®<br />\n...Evidence of MERS-CoV inducing type I IFN only weakly and late in infection (9&ndash;15) suggests that MERS-CoV has also evolved mechanisms to evade the host immune system. In fact, MERS-CoV M, ORF4a, ORF4b and ORF5 proteins are reported to be strong IFN antagonists [18]. Further studies, using the transient overexpression of MERS-CoV accessory protein ORF4a, ORF4b, and ORF5, show that the MERS-CoV accessory proteins inhibit both type I IFN induction [18,27,28] and NF-kappaB signaling pathways [28]. MERS-CoV ORF4a, a double-stranded RNA (dsRNA) binding protein [27], potentially acts as an antagonist of the antiviral activity of IFN via the inhibition of both the interferon production (IFN-&beta; promoter activity, IRF-3/7 and NF-&kappa;B activation) and the ISRE promoter element signaling pathways [18]. MERS-CoV ORF4b, on the other hand, is an enzyme in the 2H-phosphoesterase (2H-PE) family with phosphodiesterase (PDE) activity. Even though MERS-CoV ORF4b is detected primarily in the nucleus of both infected and transfected cells [18,27,28], the expression levels of cytoplasmic MERS-CoV ORF4b are still sufficient to inhibit activation of RNase L, an interferon-induced potent antiviral activity [18,28]. MERS-CoV ORF4b is the first identified RNase L antagonist expressed by a human or bat coronavirus and provides a possible MERS-CoV mechanism for evasion of innate immunity by inhibiting the type I IFN and NF-kappa&beta; signaling pathways [16,28]. The MERS-CoV replicase proteins, including nsp1, nsp3 and nsp14, were also shown to interfere with the innate immune response signaling pathways through different mechanisms [21,29,30]. Evidently, MERS-CoV has developed various mechanisms to evade the host immune system....<br />\n<br />\nPMC5850400<br />\n<br />\nåˆ©ç”³ å†‡è®€évirology"}]}